Bernstein CN, Wajda A, Blanchard JF. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol 2008;6:41–45.

Article  PubMed  Google Scholar 

Osterman MT, Yang YX, Brensinger C, Forde KA, Lichtenstein GR, Lewis JD. No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn’s disease. Clin Gastroenterol Hepatol 2011;9:875–880.

Article  PubMed  PubMed Central  Google Scholar 

Rungoe C, Basit S, Ranthe MF, Wohlfahrt J, Langholz E, Jess T. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut 2013;62:689–694.

Article  CAS  PubMed  Google Scholar 

Fumery M, Xiaocang C, Dauchet L, Gower-Rousseau C, Peyrin-Biroulet L, Colombel JF. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies. J Crohns Colitis 2014;8:469–479.

Article  PubMed  Google Scholar 

Singh S, Singh H, Loftus EV, Pardi DS. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2014;12:382–93 e1: quiz e22.

Barnes EL, Beery RM, Schulman AR, McCarthy EP, Korzenik R, Winter RW. Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database. Inflamm Bowel Dis 2016;22:2229–2237.

Article  PubMed  Google Scholar 

Aniwan S, Pardi DS, Tremaine WJ, Tremaine WJ, Loftus EV. Increased Risk of Acute Myocardial Infarction and Heart Failure in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2018;16:1607-1615.e1.

Article  PubMed  PubMed Central  Google Scholar 

Card TR, Zittan E, Nguyen GC, Grainge MJ. Disease Activity in Inflammatory Bowel Disease Is Associated With Arterial Vascular Disease. Inflamm Bowel Dis 2021;27:629–638.

Article  PubMed  Google Scholar 

Bernstein CN, Nugent Z, Singh H. Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease: A Population-Based Study. Am J Gastroenterol 2021;116:1476–1484.

Article  PubMed  Google Scholar 

Panhwar MS, Mansoor E, Al-Kindi SG, Sinh P et al. Risk of Myocardial Infarction in Inflammatory Bowel Disease: A Population-based National Study. Inflamm Bowel Dis 2019;25:1080–1087.

Article  PubMed  Google Scholar 

Singh S, Kullo IJ, Pardi DS, Loftus EV. Epidemiology, risk factors and management of cardiovascular diseases in IBD. Nat Rev Gastroenterol Hepatol 2015;12:26–35.

Article  PubMed  Google Scholar 

Peyrin-Biroulet L, Loftus EV, Colombel JF, Sandborn WJ. Long-term complications, extraintestinal manifestations, and mortality in adult Crohn’s disease in population-based cohorts. Inflamm Bowel Dis 2011;17:471–478.

Article  PubMed  Google Scholar 

Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death–a Danish nationwide cohort study. PLoS One 2013;8:e56944.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 2010;375:657–663.

Article  PubMed  Google Scholar 

Ha C, Magowan S, Accortt NA, Chen J, Stone CD. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol 2009;104:1445–1451.

Article  PubMed  Google Scholar 

Roifman I, Sun YC, Fedwick JP, Panaccione R et al. Evidence of endothelial dysfunction in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2009;7:175–182.

Article  CAS  PubMed  Google Scholar 

Wu GC, Leng RX, Lu Q, Fan YG, Wang DG, Ye DQ. Subclinical Atherosclerosis in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Angiology 2017;68:447–461.

Article  PubMed  Google Scholar 

Nevulis MG, Baker C, Lebovics E, Frishman WH. Overview of Link Between Inflammatory Bowel Disease and Cardiovascular Disease. Cardiol Rev 2018;26:287–293.

Article  PubMed  Google Scholar 

Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135–1143.

Article  CAS  PubMed  Google Scholar 

Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363–368.

Article  PubMed  Google Scholar 

Frostegard J. Systemic lupus erythematosus and cardiovascular disease. Lupus 2008;17:364–367.

Article  CAS  PubMed  Google Scholar 

Manzi S, Meilahn E, Rairie J, Conte C et al. Age-specific incidence MI angina women SLE Framingham comparison. American Journal of Epidemiology 1997;145:408–415.

Article  CAS  PubMed  Google Scholar 

Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 2015;11:693–704.

Article  CAS  PubMed  Google Scholar 

Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2012;71:1524–1529.

Article  PubMed  Google Scholar 

Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010;375:132–140.

Article  PubMed  Google Scholar 

Bigeh A, Sanchez A, Maestas C, Gulati M. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease? Trends Cardiovasc Med 2020;30:463–469.

Article  CAS  PubMed  Google Scholar 

Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006;145:21–29.

Article  CAS  PubMed  Google Scholar 

El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN et al. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. Circulation 2020;142:e506–e532.

Article  PubMed  Google Scholar 

El Khoudary SR, Wildman RP, Matthews K, Thurston RC et al. Endogenous sex hormones impact the progression of subclinical atherosclerosis in women during the menopausal transition. Atherosclerosis 2012;225:180–186.

Article  PubMed  PubMed Central  Google Scholar 

Matthews KA, Crawford SL, Chae CU, Everson-Rose SA et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 2009;54:2366–2373.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gurka MJ, Vishnu A, Santen RJ, DeBoer MD. Progression of Metabolic Syndrome Severity During the Menopausal Transition. J Am Heart Assoc 2016;5.

Maas A, Rosano G, Cifkova R, Chieffo A et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J 2021;42:967–984.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998;19:61–109.

Curb JD, McTiernan A, Heckbert SR, Koperberg C et al. Outcomes ascertainment and adjudication methods in the Women’s Health Initiative. Ann Epidemiol 2003;13:S122–S128.

Article  PubMed  Google Scholar 

Sprague BL, Trentham-Dietz A, Cronin KA. A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999–2010. Obstet Gynecol 2012;120:595–603.

Article  PubMed  PubMed Central  Google Scholar 

Ridker PM, Cook NR, Lee IM, Gordon D et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293–1304.

Article  CAS  PubMed  Google Scholar 

Abdelaziz HK, Saad M, Pothineni NVK, Megaly M et al. Aspirin for Primary Prevention of Cardiovascular Events. J Am Coll Cardiol 2019;73:2915–2929.

Article  PubMed  Google Scholar 

Davidson KW, Barry MJ, Mangione M, Cabana CM et al. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. JAMA 2022;327:1577–1584.

Article  PubMed  Google Scholar 

Kvasnovsky CL, Aujla U, Bjarnason I. Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease. Scand J Gastroenterol 2015;50:255–263.

Article  CAS  PubMed  Google Scholar 

Patel P, Gao G, Gulotta G, Dalal S et al. Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:236–241.

Article  PubMed  Google Scholar 

Takeuchi K, Smale S, Premchand P, Maiden L, et al. Prevalence and mechanism of NSAID clinical relapse in I